These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 36847987)

  • 1. R0 Resection in Recurrent Gynecologic Malignancy: Pelvic Exenteration and Beyond.
    Xu C; Garda AE; Kumar A
    Curr Treat Options Oncol; 2023 Apr; 24(4):262-273. PubMed ID: 36847987
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends and current aspects of reconstructive surgery for gynecological cancers.
    Loverro M; Aloisi A; Tortorella L; Aletti GD; Kumar A
    Int J Gynecol Cancer; 2024 Mar; 34(3):426-435. PubMed ID: 38438169
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Does intra-operative radiation at the time of pelvic exenteration improve survival for patients with recurrent, previously irradiated cervical, vaginal, or vulvar cancer?
    Backes FJ; Billingsley CC; Martin DD; Tierney BJ; Eisenhauer EL; Cohn DE; O'Malley DM; Salani R; Copeland LJ; Fowler JM
    Gynecol Oncol; 2014 Oct; 135(1):95-9. PubMed ID: 25084510
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pelvic exenteration for advanced pelvic malignancy.
    Crowe PJ; Temple WJ; Lopez MJ; Ketcham AS
    Semin Surg Oncol; 1999; 17(3):152-60. PubMed ID: 10504662
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pelvic exenteration: long-term oncological results in a series of 106 patients.
    De Wever I
    Acta Chir Belg; 2011; 111(5):282-7. PubMed ID: 22191128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Laparoscopic pelvic exenteration and laterally extended endopelvic resection for postradiation recurrent cervical carcinoma: Technical feasibility and short-term oncologic outcome.
    Kanao H; Aoki Y; Omi M; Nomura H; Tanigawa T; Okamoto S; Chang EJ; Kurita T; Netsu S; Matoda M; Omatsu K; Matsuo K
    Gynecol Oncol; 2021 Apr; 161(1):34-38. PubMed ID: 33423805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pelvic exenteration for gynaecological tumours: achievements and unanswered questions.
    Höckel M; Dornhöfer N
    Lancet Oncol; 2006 Oct; 7(10):837-47. PubMed ID: 17012046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pelvic exenteration for gynecologic malignancies: Postoperative complications and oncologic outcomes.
    Romeo A; Gonzalez MI; Jaunarena J; Zubieta ME; Favre G; Tejerizo JC
    Actas Urol Esp (Engl Ed); 2018 Mar; 42(2):121-125. PubMed ID: 28911880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pelvic Exenteration as Potential Cure and Symptom Relief in Advanced and Recurrent Gynaecological Cancer.
    Soeda S; Furukawa S; Sato T; Ueda M; Kamo N; Endo Y; Kojima M; Nomura S; Kataoka M; Fujita S; Endo H; Takahashi T; Watanabe T; Yamada H; Fujimori K
    Anticancer Res; 2019 Oct; 39(10):5631-5637. PubMed ID: 31570460
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Laterally extended endopelvic resection (LEER)--principles and practice.
    Höckel M
    Gynecol Oncol; 2008 Nov; 111(2 Suppl):S13-7. PubMed ID: 18723213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pelvic exenteration for recurrent gynecologic malignancy: a study of 28 consecutive patients at a single institution.
    Jäger L; Nilsson PJ; Rådestad AF
    Int J Gynecol Cancer; 2013 May; 23(4):755-62. PubMed ID: 23407096
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Laparoscopic laterally extended endopelvic resection procedure for gynecological malignancies.
    Sozzi G; Petrillo M; Gallotta V; Di Donna MC; Ferreri M; Scambia G; Chiantera V
    Int J Gynecol Cancer; 2020 Jun; 30(6):853-859. PubMed ID: 32332122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pelvic exenteration for recurrent or persistent gynecologic malignancies: Clinical and histopathologic factors predicting recurrence and survival in a modern cohort.
    Straubhar AM; Chi AJ; Zhou QC; Iasonos A; Filippova OT; Leitao MM; Awowole IO; Abu-Rustum NR; Broach VA; Jewell EL; Sandhu JS; Sonoda Y
    Gynecol Oncol; 2021 Nov; 163(2):294-298. PubMed ID: 34518053
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pelvic exenteration for recurrent gynecologic malignancy: survival and morbidity analysis of the 45-year experience at UCLA.
    Berek JS; Howe C; Lagasse LD; Hacker NF
    Gynecol Oncol; 2005 Oct; 99(1):153-9. PubMed ID: 16054678
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimally Invasive Pelvic Exenteration for Gynecologic Malignancies: A Multi-Institutional Case Series and Review of the Literature.
    Bizzarri N; Chiantera V; Ercoli A; Fagotti A; Tortorella L; Conte C; Cappuccio S; Di Donna MC; Gallotta V; Scambia G; Vizzielli G
    J Minim Invasive Gynecol; 2019; 26(7):1316-1326. PubMed ID: 30611973
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pelvic exenteration for recurrent or persistent gynecologic malignancies: a 10-year review of the Memorial Sloan-Kettering Cancer Center experience (1972-1981).
    Lawhead RA; Clark DG; Smith DH; Pierce VK; Lewis JL
    Gynecol Oncol; 1989 Jun; 33(3):279-82. PubMed ID: 2722049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extended pelvic resection for gynecological malignancies: A review of out-of-the-box surgery.
    Daix M; Martinez Gomez C; Angeles MA; Tock S; Gladieff L; Gabiache E; Mery E; Martinez A; Cibula D; Ferron G
    Gynecol Oncol; 2022 May; 165(2):393-400. PubMed ID: 35331571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pelvic Exenteration in Advanced Gynecologic Malignancies - Who Will Benefit?
    Egger EK; Liesenfeld H; Stope MB; Recker F; Döser A; Könsgen D; Marinova M; Hilbert T; Exner D; Ellinger J; Mustea A
    Anticancer Res; 2021 Jun; 41(6):3037-3043. PubMed ID: 34083295
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics of gynecologic oncology patients in King Chulalongkorn Memorial Hospital - complications and outcome of pelvic exenteration.
    Oranratanaphan S; Termrungruanglert W; Sirisabya N
    Asian Pac J Cancer Prev; 2013; 14(4):2529-32. PubMed ID: 23725169
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of pelvic exenteration and reconstruction for treatment of advanced or recurrent gynecologic malignancies: Analysis of risk factors predicting recurrence and survival.
    Park JY; Choi HJ; Jeong SY; Chung J; Park JK; Park SY
    J Surg Oncol; 2007 Dec; 96(7):560-8. PubMed ID: 17708548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.